文献速递妇科

多腔室深部子宫内膜异位症一期腹腔镜切除的围手术期并发症与复发:多中心队列研究

Perioperative Morbidity and Recurrence After One-Stage Laparoscopic Resection for Multicompartment Deep Endometriosis: A Multicentre Cohort Study.
PubMed 文献 · BJOG · 2026-11-02

回顾性多中心队列研究纳入299例病理确诊的深部子宫内膜异位症患者,均接受一期腹腔镜多腔室切除。术后临床相关并发症(Clavien-Dindo≥II级)发生率为11.7%,#ENZIAN深部内异症解剖范围每增加一个受累腔室与并发症独立相关(aOR 1.51,95%CI 1.04-2.18)。复发率14.4%,8.7%再次手术;肠管或膀胱手术方式与无复发生存无显著差异。

要点

  • #ENZIAN解剖范围越广,一期术后临床相关并发症风险越高
  • 术后临床相关并发症(≥II级)发生率为11.7%,≥IIIb级为4.7%
  • 复发率14.4%,再次手术率8.7%;肠管或膀胱术式与复发无显著相关

核心结论

  • #ENZIAN深部内异症解剖范围越大,一期多腔室手术后临床相关并发症风险越高,提示整体解剖范围比单一部位受累更能反映手术复杂性。

研究设计与样本

  • 回顾性多中心队列研究,纳入2017年1月至2025年12月在两家三级转诊中心接受一期腹腔镜多腔室深部内异症切除、病理确诊的299例连续患者。

主要发现

  • 术后并发症36/299例(12.0%),其中Clavien-Dindo≥II级35/299例(11.7%),≥IIIb级14/299例(4.7%)。
  • #ENZIAN深部内异症解剖范围每增加一个受累腔室,临床相关并发症风险独立增加(aOR 1.51,95%CI 1.04-2.18)。
  • 复发43/299例(14.4%),因复发再次手术26/299例(8.7%);231/299例(77.3%)有随访时间数据。
  • 无复发生存率按肠管手术方式(log-rank p=0.431)或膀胱手术方式(p=0.116)比较均无显著差异。

关键数值与推荐

  • 临床相关术后并发症定义为Clavien-Dindo分级≥II级。
  • #ENZIAN深部内异症解剖范围与临床相关并发症的校正比值比为1.51(每增加一个受累腔室,95%CI 1.04-2.18)。
  • 肠管手术方式与无复发生存无关(log-rank p=0.431),膀胱手术方式亦无关(p=0.116)。

临床怎么用

  • 术前咨询和个体化手术规划应纳入#ENZIAN评估的整体解剖范围,而非仅关注单一部位受累。
  • 对多腔室受累患者应充分告知临床相关并发症风险升高,并据此制定围手术期管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate perioperative morbidity, factors associated with postoperative complications and documented recurrence after one-stage laparoscopic resection for multicompartment deep endometriosis. DESIGN: Retrospective multicentre cohort study. SETTING: Two tertiary referral centres specialised in endometriosis surgery (Bern, Switzerland; Budapest, Hungary). POPULATION: A total of 299 consecutive patients with pathologically confirmed deep endometriosis undergoing one-stage laparoscopic resection between January 2017 and December 2025. INTERVENTIONS: One-stage laparoscopic resection of multicompartment deep endometriosis. MEASUREMENTS AND MAIN RESULTS: Clinically relevant postoperative complications were defined as Clavien-Dindo Grade ≥ II. Multivariable logistic regression assessed associated factors. Recurrence-free survival was evaluated using Kaplan-Meier analysis in patients with an available recurrence time or censoring time. Postoperative complications occurred in 36/299 patients (12.0%), including 35/299 (11.7%) with Grade ≥ II complications and 14/299 (4.7%) with Grade ≥ IIIb complications. Greater #ENZIAN deep endometriosis anatomical extent was independently associated with clinically relevant complications (adjusted odds ratio 1.51 per additional involved compartment, 95% confidence interval 1.04-2.18). Documented recurrence occurred in 43/299 patients (14.4%) and 26/299 (8.7%) underwent reoperation for recurrence. Follow-up duration was available for 231/299 patients (77.3%). Recurrence-free survival did not differ significantly according to bowel (log-rank p = 0.431) or bladder surgical technique (p = 0.116). CONCLUSION: Greater #ENZIAN deep endometriosis anatomical extent was independently associated with clinically relevant postoperative complications following one-stage surgery for multicompartment deep endometriosis, suggesting that overall anatomical disease extent may better reflect surgical complexity than involvement of a single anatomical site. These findings support the role of anatomical disease extent in preoperative counselling and individualised surgical planning.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Pagano F, Sík PB, Imboden S, et al. Perioperative Morbidity and Recurrence After One-Stage Laparoscopic Resection for Multicompartment Deep Endometriosis: A Multicentre Cohort Study. BJOG. 2026. PMID: 42972913. doi:10.1111/1471-0528.70366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。